Selective serotonin re-uptake inhibition attenuates evoked glutamate release in the dorsal horn of the anaesthetised rat in vivo

Pharmacological Research

Volumn 53, Issue 2, 2006, Pages 149-155

  Langman, N J ^a   Smith, C G S ^a   Whitehead, K J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Glutamate; Microdialysis; Pain; Selective serotonin re uptake inhibitor; Spinal cord

Indexed keywords

ASPARTIC ACID; CALCIUM; CITALOPRAM; GLUTAMIC ACID; MAGNESIUM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; POTASSIUM; SEROTONIN 1A ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; VOLTAGE GATED CALCIUM CHANNEL;

AMINO ACID TRANSPORT; ANALGESIA; ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG SELECTIVITY; EXTRACELLULAR FLUID; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SEROTONINERGIC SYSTEM; SPINAL CORD DORSAL HORN;

ANESTHESIA; ANIMALS; ASPARTIC ACID; CITALOPRAM; GLUTAMIC ACID; MALE; MICRODIALYSIS; PAROXETINE; PIPERAZINES; POSTERIOR HORN CELLS; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 29344475741     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.10.003     Document Type: Article

References (46)

1. M.J. Millan Descending control of pain Prog Neurobiol 66 2002 355 474
2. C.Y. Jeong, J.I. Choi, and M.H. Yoon Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats Eur J Pharmacol 502 2004 205 211
3. R. Suzuki, L.J. Rygh, and A.H. Dickenson Bad news from the brain: descending 5-HT pathways that control spinal pain processing Trends Pharmacol Sci 25 2004 615 617
4. H.J. McQuay, M. Tramer, B.A. Nye, D. Carroll, P. Wiffen, and A. Moore A systematic review of antidepressants in neuropathic pain Pain 68 1996 217 227
5. A.J. Smith The analgesic effects of selective serotonin reuptake inhibitors J Psychopharmacol 12 1998 407 413
6. 3 receptors evokes GABA release in the spinal cord Brain Res 978 2003 250 255
7. Y. Kuraishi, M. Minami, and M. Satoh Serotonin, but neither noradrenaline nor GABA, inhibits capsaicin-evoked release of immunoreactive somatostatin from slices of rat spinal cord Neurosci Res 9 1991 238 245
8. K.J. Whitehead, S.M. Pearce, and N.G. Bowery Characterisation of 5-HT efflux from the rat spinal cord dorsal horn in vivo Br J Pharmacol 129 Suppl. 2000 62P
9. K.J. Whitehead, S.M. Pearce, G. Walker, H. Sundaram, D. Hill, and N.G. Bowery Positive N-methyl-d-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo Neuroscience 126 2004 381 390
10. Roth BL, Lopez E. http://serotoninclub.org/serotoninclub/.
11. B.H.C. Westerink, H.M. Hofsteede, G. Damsma, and J.B. de Vries The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis NS Arch Pharmacol 337 1988 373 378
12. W. Timmerman, and B.H.C. Westerink Brain dialysis of GABA and glutamate: what does it signify? Synapse 27 1997 242 261
13. C.-L. Gong, Y.-T. Chiu, N.-N. Lin, S.-Z. Lin, F.-C. Cheng, and J.-S. Kuo Inhibitory actions of serotonin on glutamate release in dorsal medulla suppress systemic arterial pressure of cats Neurosci Lett 355 2004 73 76
14. B.H.C. Westerink, R.M. Hofsteede, J. Tuntler, and J.B. de Vries Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis J Neurochem 52 1989 722 729
15. A. Imperato, T. Honore, and L.H. Jensen Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely moving rats Brain Res 530 1990 223 228
16. H. Benveniste, A.J. Hansen, and N.S. Ottosen Determination of brain interstitial concentrations by microdialysis J Neurochem 52 6 1989 1741 1750
17. L. Jasmin, D. Tien, G. Janni, and P.T. Ohara Is noradrenaline a significant factor in the analgesic effect of antidepressants? Pain 106 2003 3 8
18. Y. Kawasaki, E. Kumamoto, H. Furue, and M. Yoshimura α2 Adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons Anaesthesiology 98 2003 682 689
19. L. Bardin, M. Bardin, J. Lavarenne, and A. Eschalier Effect of intrathecal serotonin on nociception in rats: influence of the pain test used Exp Brain Res 113 1997 81 87
20. L. Bardin, J. Lavarenne, and A. Eschalier Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats Pain 86 2000 11 18
21. 2+ entry Brain Res 701 1995 249 254
22. F. Mauler, T. Fahrig, E. Horvath, and R. Jork Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo Brain Res 888 2001 150 157
23. 1A receptors Eur J Neurosci 10 1998 2163 2172
24. G. Daval, D. Vergé, A.I. Basbaum, S. Bourgoin, and M. Hamon Autoradiographic evidence of serotonergic binding sites in primary afferent fibres in the dorsal horn of the rat spinal cord Neurosci Lett 83 1987 71 76
25. D. Schmitz, T. Gloveli, R.M. Emson, and U. Heinemann Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex Mol Neurobiol 17 1998 59 72
26. J.G. Valtschanoff, R.J. Weinberg, and A. Rustioni Amino acid reactivity in corticospinal terminals Exp Brain Res 93 1993 95 103
27. 3 receptors in the aged human spinal cord J Chem Neuroanat 11 1996 67 75
28. 1/2 receptors in streptozotocin-induced diabetic mice Eur J Pharmacol 497 2004 285 292
29. 1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury Eur J Pharmacol 497 2004 29 33
30. A. Adell, and F. Artigas A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat Br J Pharmacol 125 1998 1361 1367
31. Y. Sari Serotonin1B receptors: from protein to physiological function and behavior Neurosci Biobehav Rev 28 6 2004 565 582
32. G. Maura, M. Marcoli, M. Tortarlol, G.C. Androli, and M. Raiteri Glutamate release in the human cerebral cortex and its modulation by 5-hydroxytryptamine acting at 5-HT1D receptors Br J Pharmacol 123 1998 45 50
33. G. Maura, and M. Raiteri Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro J Neurochem 66 1 1996 203 209
34. E.A. Jennings, R.M. Ryan, and M.J. Christie Effects of sumatriptan on rat medullary dorsal horn neurons Pain 111 1/2 2004 30 37
35. 3 receptor-mediated antinociception: possible release of GABA J Neurosci 11 1991 1881 1888
36. P.A. Lavoie, G. Beauchamp, and R. Elie Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes Can J Physiol Pharmacol 75 1997 983 987
37. F. Deák, B. Lasztóczi, P. Pacher, G.L. Petheö, V. Kecskeméti, and A. Spät Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells Neuropharmacology 39 2000 1029 1036
38. E. Yaris, M. Kesim, M. Kadioglu, N.I. Kalyoncu, C. Ulku, and R. Ozyavuz The effects of paroxetine on rat isolated vas deferens Pharmacol Res 48 2003 335 345
39. N.I. Kalyoncu, R. Ozyavuz, and S. Karaoglu Sertaline inhibits the contractile responses to noradrenaline, KCl and electrical field stimulation of rat isolated vas deferens J. Auton Pharmacol 19 1999 365 369
40. 2+-channel inhibition Life Sci 50 1992 2125 2138
41. 2+ channels Synapse 48 2003 170 177
42. S.-J. Wang Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex Synapse 55 2005 156 163
43. Y.-X. Wang, M. Pettus, D. Gao, C. Phillips, and S.S. Bowersox Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain Pain 84 2/3 2000 151 158
44. A. Dogrul, L.R. Gardell, M.H. Ossipov, F.C. Tulunay, J. Lai, and F. Porreca Reversal of experimental neuropathic pain by T-type calcium channel blockers Pain 105 1/2 2003 159 168
45. S.H. Sindrup, E. Grodum, L.F. Gram, and H. Beck-Nielsen Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study Ther Drug Monit 13 5 1991 408 414
46. C.N. Karson, J.E. Newton, R. Livingston, J.B. Jolly, T.B. Cooper, and J. Sprigg Human brain fluoxetine concentrations J Neuropsychol Clin Neurosci 5 1993 322 329